Substituted chiral fused [1,2]imidazo[4,5-C] ring compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8350034
APP PUB NO 20110293654A1
SERIAL NO

13196131

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Substituted fused [1,2]imidazo[4,5-c] ring compounds (e.g., imidazo[4,5-c]quinolines, 6,7,8,9-tetrahydroimidazo[4,5-c]quinolines, imidazo[4,5-c]naphthyridines, and 6,7,8,9-tetrahydroimidazo[4,5-c]naphthyridines) with a —CH(—R1)— group in the fused ring at the 1-position of the imidazo ring, wherein R1 includes a functional group, for example, an amide, sulfonamide, urea, carbamate, ester, ketone, ether, a thio analog of the forgoing, sulfone, oxime, or hydroxylamine, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
3M INNOVATIVE PROPERTIES COMPANYSAINT PAUL MINNESOTA 55133-3427

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Danielson, Michael E St. Paul, US 25 917
Griesgraber, George W Eagan, US 139 4750
Kshirsagar, Tushar A Woodbury, US 59 2626
Slania, Sarah J Eagan, US 8 170

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation